Long-term efficacy and safety of larotrectinib in patients with TRK fusion lung cancer.

被引：0
|
作者：
Drilon, Alexander E.
Kummar, Shivaani
Lin, Jessica Jiyeong
Tan, Daniel Shao-Weng
Moreno, Victor
Leyvraz, Serge
Dubashi, Biswajit
Haresh, K. P.
Burcoveanu, Domnita-Ileana
Neu, Natascha
Mussi, Chiara E.
Shen, Lin
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] Oregon Hlth & Sci Univ, Portland, OR USA
[4] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Duke NUS Med Sch, Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore
[7] Hosp Fdn Jimenez Diaz, START Madrid, Madrid, Spain
[8] Charit Univ Med Berlin, Berlin, Germany
[9] Jawaharlal Inst Postgrade Med Educ & Res, Pondicherry, India
[10] All India Inst Med Sci AIIMS, New Delhi, India
[11] Bayer HealthCare Pharmaceut Inc, Basel, Switzerland
[12] Chrestos Concept GmbH & Co KG, Essen, Germany
[13] Bayer SpA, Milan, Italy
[14] Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing Key Lab Carcinogenesis & Translat Res, State Key Lab Holist Integrat Management Gastroin, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8570
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer
    Drilon, A.
    Moreno, V.
    Patel, J.
    Lassen, U.
    Solomon, B.
    Rosen, L.
    Leyvraz, S.
    Tan, D. S. W.
    Reeves, J. A.
    Dima, L.
    Brega, N.
    Kummar, S.
    Farago, A. F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S30 - S31
  • [22] Long-term outcomes of patients with TRK fusion cancer treated with larotrectinib.
    Drilon, Alexander
    Kummar, Shivaani
    Albert, Catherine M.
    Nagasubramanian, Ramamoorthy
    Hechtman, Jaclyn F.
    Reeves, John A.
    Beckmann, Georg
    Rudolph, Marion
    Wierzbinska, Justyna A.
    Dima, Laura
    Brega, Nicoletta
    Laetsch, Theodore W.
    Hong, David S.
    CANCER RESEARCH, 2021, 81 (13)
  • [23] Updated efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion gastrointestinal (GI) cancer.
    Shen, Lin
    Andre, Thierry
    Chung, Hyun Cheol Cheol
    Deeken, John F.
    Garralda, Elena
    Italiano, Antoine
    Leyvraz, Serge
    Liu, Tianshu
    Burcoveanu, Domnita-Ileana
    Grugel, Robin
    Mussi, Chiara E.
    Xu, Rui-Hua
    Hong, David S.
    Drilon, Alexander E.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 109 - 109
  • [24] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An expanded dataset
    Garralda, E.
    Hong, D.
    Xu, R.
    Deeken, J.
    Italiano, A.
    Liu, T.
    Ferrandiz, A.
    Patel, J.
    Lee, D.
    Chung, H.
    Kinoshita, I.
    Berlin, J.
    Andre, T.
    Oh, D.
    Leyvraz, S.
    Miguel, M.
    Liu, Y.
    Norenberg, R.
    Fellous, M.
    Mussi, C.
    Drilon, A.
    Shen, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S370 - S370
  • [25] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An updated analysis
    Andre, T.
    Hong, D.
    Deeken, J.
    Italiano, A.
    Liu, T.
    Burcoveanu, D.
    Norenberg, R.
    Mussi, C.
    Xu, R.
    Drilon, A.
    Shen, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S12 - S13
  • [26] LONG-TERM FOLLOW-UP OF THE EFFICACY AND SAFETY OF LAROTRECTINIB IN PAEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER
    Federman, Noah
    Van Tilburg, Cornelis
    Dierselhuis, Miranda
    Albert, Catherine
    Geoerger, Birgit
    Dubois, Steven
    Mascarenhas, Leo
    Nagasubramanian, Ramamoorthy
    Pappo, Alberto
    Watt, Tanya
    Bernard-Gauthier, Vadim
    Norenberg, Ricarda
    De la Cuesta, Esther
    Doz, Francois
    Zhang, Yizhuo
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [27] Larotrectinib efficacy and safety in adult TRK fusion cancer patients.
    Hong, David S.
    Kummar, Shivaani
    Farago, Anna F.
    Lassen, Ulrik Niels
    Berlin, Jordan
    Schilder, Russell J.
    McDermott, Raymond S.
    Patel, Jyoti D.
    Dowlati, Afshin
    Doebele, Robert Charles
    Tan, Daniel Shao-Weng
    Lee, James J.
    Nanda, Shivani
    Childs, Barrett H.
    Ku, Nora
    Drilon, Alexander E.
    Hyman, David Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] Larotrectinib efficacy and safety in pediatric TRK fusion cancer patients.
    van Tilburg, Cornelis Martinus
    DuBois, Steven G.
    Albert, Catherine Michelle
    Federman, Noah
    Nagasubramanian, Ramamoorthy
    Geoerger, Birgit
    Orbach, Daniel
    Bielack, Stefan S.
    Shukla, Neerav Narendra
    Turpin, Brian
    Casanova, Michela
    Spunt, Sheri L.
    Qamoos, Hope
    Nanda, Shivani
    Childs, Barrett H.
    Cox, Michael Craig
    Pappo, Alberto S.
    Laetsch, Theodore Willis
    Mascarenhas, Leo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Updated Efficacy, Safety, and Biomarker Analysis in Patients with TRK Fusion Lung Cancer Treated with Larotrectinib
    Lin, J. J.
    Tan, D. S. W.
    Kummar, S.
    Moreno, V.
    Leyvraz, S.
    Dubashi, B.
    Parambath, H.
    Burcoveanu, D. -I.
    Neu, N.
    Leserer, S.
    Seidel, H.
    Mussi, C. E.
    Shen, L.
    Drilon, A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S77 - S77
  • [30] Extended Follow-up of Efficacy and Safety of Larotrectinib in Patients With TRK Fusion Lung Cancer
    Moreno, V.
    Lin, J. J.
    Tan, D. S. W.
    Kummar, S.
    Dai, M. -S.
    Lassen, U. N.
    Leyvraz, S.
    Liu, Y.
    Patel, J. D.
    Rosen, L.
    Solomon, B.
    Yachnin, J.
    Norenberg, R.
    Fellous, M.
    Mussi, C. E.
    Shen, L.
    Drilon, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S473 - S474
12345